They're leaders in their markets. And those markets should grow tremendously.
News & Analysis: Guardant Health
Roku, Guardant Health, and Carvana have all soared to start the year. Should the buyer beware or let the good times roll?
A new study is planned that could someday reshape colon cancer screenings.
Earnings and acquisition activity helped make these stocks stand out.
Traders bid up the stock in response to another strong earnings report.
GH earnings call for the period ending March 31, 2019.
These next-generation companies are working on game-changing ways to obtain and profit from genetic insight.
Positive comments and favorable industry conditions helped lift several stocks.
What went up then came down again is going back up again.
The liquid biopsy pioneer has been riding a wave of favorable news lately.